(Q69812259)
Statements
A randomized comparison of high-dose versus conventional-dose cyclophosphamide, doxorubicin, and vincristine for extensive-stage small-cell lung cancer: a phase III trial of the Southeastern Cancer Study Group (English)
D H Johnson
L H Einhorn
R Birch
R Vollmer
C Perez
S Krauss
G Omura